Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

January 01, 1998; 50 (1) Editorials

Why do patients with McArdle's disease have decreased exercise capacity?

Robert L. Ruff
First published January 1, 1998, DOI: https://doi.org/10.1212/WNL.50.1.6
Robert L. Ruff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Why do patients with McArdle's disease have decreased exercise capacity?
Robert L. Ruff
Neurology Jan 1998, 50 (1) 6-7; DOI: 10.1212/WNL.50.1.6

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
66

Share

  • Article
  • Info & Disclosures
Loading

Disorders of myoglycogenolysis, such as myophosphorylase deficiency(McArdle's disease), and myoglycolysis, such as phosphofructokinase deficiency (Tarui disease), are characterized by electrically silent, exercise-provoked contractions called "contractures," premature exertional fatigue and excessive cardiovascular responses to exercise.1-3 McArdle's disease and Tarui disease as well as other disorders of myoglycolysis, such as phosphoglycerate kinase deficiency, phosphoglycerate mutase deficiency, and lactate dehydrogenase deficiency, are important to neurology because these disorders allow us to explore the interactions between muscle metabolism and muscle contraction.1 Beyond providing the power for movement, skeletal muscle is the largest protein store in the human body and is important in the regulation of glucose metabolism.4 The article by Haller et al.5 in this issue of Neurology focuses on physiologic alterations of skeletal muscle in McArdle's disease that contribute to exercise intolerance and exaggerated cardiovascular responses to exercise. Their work represents the collaboration of well-respected muscle physiologists from both sides of the Atlantic Ocean.

Contracture was initially thought to be similar to the rigor of rigor mortis. Ischemic exercise would deplete adenosine triphosphate (ATP) because the muscle fiber could not generate ATP through the glycolytic pathway under anaerobic conditions. Without ATP, cycling of the contractile protein cross-bridges would stop, and the cross-bridges would lock in a rigor state. This initial explanation of contracture, although superficially tempting, was not true. Rowland et al.6 demonstrated that contractures in McArdle's disease were not caused by depletion of ATP. Subsequent studies utilizing phosphorus magnetic resonance spectroscopy demonstrated that ATP was not depleted during exercise in patients with McArdle's disease,7,8 Tarui disease,9-11 or other disorders of human muscle glycolysis or glycogenolysis.12,13 Experiments using an animal model of Tarui disease in which the glycolytic enzyme glyceraldehyde-3-phosphate was blocked14 demonstrated four important differences between muscles with impaired glycolysis at the onset of contracture and ischemically exercised control muscles15,16: (1) adenosine diphosphate (ADP) values increased more than 10-fold compared with control values; (2) intracellular pH in muscles with blocked glycolysis did not acidify in response to ischemic exercise; (3) inorganic phosphate levels in muscles with impaired glycolysis at contracture were 50% lower than in ischemically exercised control muscles; and (4) intracellular calcium level at the onset of contracture was more than 10-fold greater than in ischemically exercised control muscles. In ischemically exercised control muscles, muscle acidification and elevated inorganic phosphate reduced the calcium sensitivity of the contractile proteins.17 In contrast, the combination of increased ADP, reduced inorganic phosphate concentration, and lack of acidification in muscles with impaired glycolysis increased the calcium sensitivity of the contractile proteins.17 Therefore, contracture resulted from a combination of increased calcium sensitivity of the contractile proteins and elevated intracellular calcium.17 Contractures developed because of disruption of the complex interplay among the contractile proteins, calcium release, and calcium sequestration mechanisms. Contractures are painful and can lead to myonecrosis. To avoid contractures, patients limit their motor activities.

Haller et al.5 examined the skeletal muscle Na+-K+ pumps in patients with McArdle's disease compared with those in a group of sedentary controls. The investigators examined muscle ouabain binding and exercise-induced changes in venous potassium concentration and heart rate. Subjects with McArdle's disease had lower concentrations of Na+-K+ pumps (normalized to muscle weight), higher exercise-induced serum K+ concentrations, and greater increases in heart rate during exercise. The reduction in skeletal muscle Na+-K+ ATPase activity may be a direct consequence of the impaired glycogenolysis or may be a secondary consequence of reduced activity levels in patients. In addition, elevated intracellular ADP will reduce the transport rate of the remaining Na+-K+ pumps.3,10,18 The authors suggest that the reduced concentration of skeletal muscle Na+-K+ pumps contributes to exercise-induced hyperkalemia in subjects with McArdle's disease because the muscle is not able to uptake K+ released from skeletal muscle during contraction. Impaired uptake of K+ during muscle contraction will result in appreciable elevation of the extracellular K+ surrounding the muscle fibers. Elevated extracellular K+ will depolarize the muscle membrane, which will reduce membrane excitability due to inactivation of Na+ channels.19 Prior studies, cited by Haller et al.,5 demonstrated that the compound muscle action potential in patients with McArdle's disease progressively declines during repetitive nerve stimulation, indicating a failure in membrane excitability. Muscle force declines in parallel with the reduction in compound action potential amplitude. Consequently, the reduced skeletal muscle Na+-K+ pump activity limits the exercise potential of skeletal muscle in McArdle's disease, which will reduce the ability of skeletal muscle to contract vigorously enough to trigger a contracture.

Haller et al.5 indicate that the exaggerated extracellular potassium increase produced by exercise in patients with McArdle's disease contributes to the exaggerated cardiopulmonary responses manifested by these patients. They demonstrated that patients with McArdle's disease develop higher heart rates in response to exercise compared with sedentary control subjects. The exaggerated cardiopulmonary responses of patients with McArdle's disease will limit their exercise capacity.

Therefore, Haller et al.5 demonstrate that a lower density of Na+-K+ pumps on skeletal muscle fibers of patients with McArdle's disease limits their exercise capacity by inducing a failure of skeletal muscle fiber membrane excitability and by compromising the usual cardiopulmonary responses to exercise. The reduced exercise capacity may reduce the likelihood of contractures. Although the reduced Na+-K+ pump density may have developed in part due to reduced activity levels, the lower pump density will also protect skeletal muscle from contracture-induced injury.

Footnotes

  • Supported by The Office of Research and Development, Medical Research Service of the Department of Veterans Affairs.

    Received August 28, 1997. Accepted in final form September 12, 1997.

References

  1. 1.↵
    DiMauro S, Tsujino S. Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1554-1576.
  2. 2.
    Rowland LP. Cramps, spasms and muscle stiffness. Rev Neurol (Paris) 1985;141:261-273.
    OpenUrl
  3. 3.↵
    Lewis SF, Haller RG. Fatigue in skeletal muscle disorders. In: Atlan G, Belivau L, Bouissou P, eds. Muscle fatigue: biochemical chemical and physiological aspects. Paris: Masson, 1991:119-134.
  4. 4.↵
    Kaminski HJ, Ruff RL. Endocrine myopathies (hyper- and hypofunction of adrenal, thyroid, pituitary glands and iatrogenic glucocorticoid myopathy). In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1726-1753.
  5. 5.↵
    Haller RG, Clausen T, Vissing J. Reduced levels of skeletal muscle NA+-K+ ATPase in McArdle disease. Neurology 1998;50:37-40.
    OpenUrlFREE Full Text
  6. 6.↵
    Rowland LP, Araki S, Carmel P. Contracture in McArdle's disease: stability of adenosine triphosphate during contracture in phosphorylase-deficient muscle. Arch Neurol 1965;13:541-544.
    OpenUrl
  7. 7.↵
    Argov Z, Bank WJ, Maris J, Chance B. Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy. Neurology 1987;37:1720-1724.
    OpenUrlFREE Full Text
  8. 8.
    Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconer-Smith J. Examination of a case of suspected McArdle's syndrome by31 P nuclear magnetic resonance. N Engl J Med 1981;304:1338-1342.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Chance B, Eleff S, Bank W, Leigh JS, Warnell R.31 P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle. Proc Natl Acad Sci USA 1982;79:7714-7718.
    OpenUrl
  10. 10.
    Bertocci LA, Haller RG, Lewis SF, Fleckenstein JL, Nunnally RL. Abnormal high-energy phosphate metabolism in human muscle phosphofructokinase deficiency. J Appl Physiol 1991;70:1201-1207.
    OpenUrlAbstract/FREE Full Text
  11. 11.
    Argov Z, Bank WJ, Maris J, Leigh JS. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by31 P nuclear magnetic resonance spectroscopy. Ann Neurol 1987;22:46-51.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Argov Z, Bank WJ, Boden B, Young R, Chance B. Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis: an in vivo study of phosphoglycerate mutase deficiency. Arch Neurol 1987;44:614-617.
    OpenUrlCrossRef
  13. 13.
    Duboc D, Jehenson P, Tran Dinh S, Marsac C, Syrota A, Fardeau M. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology 1987;37:663-671.
    OpenUrl
  14. 14.↵
    Brumback RA. Iodoacetate inhibition of glyceraldehyde 3-phosphate dehydrogenase as a model of human myophosphorylase deficiency(McArdle's disease) and phosphofructokinase deficiency (Tarui's disease). J Neurol Sci 1980;8:383-398.
    OpenUrlPubMed
  15. 15.↵
    Ruff RL, Weissman J. Iodoacetate-induced contracture in rat skeletal muscle: possible role of ADP. Am J Physiol 1991;261(Cell Physiol 30):C828-C836.
  16. 16.
    Ruff RL, Weissman J. Iodoacetate-induced skeletal muscle contracture: changes in ADP, calcium, phosphate and pH. Am J Physiol 1995;268(Cell Physiol 37):C317-C322.
  17. 17.↵
    Ruff RL. Elevated intracellular Ca2+ and myofibrillar Ca2+ sensitivity cause iodoacetate-induced muscle contractures. J Appl Physiol 1996;81:1230-1239.
    OpenUrlFREE Full Text
  18. 18.
    Clausen T. Regulation of active Na+-K+ transport in skeletal muscle. Physiol Rev 1986;66:542-580.
    OpenUrl
  19. 19.↵
    Ruff RL. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fibre types. Acta Physiol Scand 1996;156:159-168.
    OpenUrlPubMed
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (4)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise